Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.08M | -9.83M | -9.84M | -10.90M | -10.30M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 578.60K | 771.50K | 771.50K | 771.50K |
| Total Other Non-Cash Items | 784.00K | 773.00K | 681.80K | 1.50K | 326.30K |
| Change in Net Operating Assets | -907.90K | -859.80K | -857.20K | 1.70M | 1.79M |
| Cash from Operations | -10.21M | -9.33M | -9.25M | -8.43M | -7.42M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.00M | 4.00M | -- | -- | -- |
| Cash from Investing | 4.00M | 4.00M | -- | -- | -- |
| Total Debt Issued | 227.30K | 227.30K | 2.46M | 2.62M | 2.23M |
| Total Debt Repaid | -3.23M | -3.30M | -3.33M | -3.59M | -709.00K |
| Issuance of Common Stock | 79.20K | 79.20K | 2.64M | 2.64M | 6.52M |
| Repurchase of Common Stock | -1.10K | -1.10K | -1.10K | -- | -- |
| Issuance of Preferred Stock | 15.02M | 15.02M | 15.02M | 15.02M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.10M | 12.02M | 16.78M | 16.69M | 8.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.89M | 6.69M | 7.53M | 8.26M | 625.10K |